ArticleJournal of translational medicine2024

Co-targeting TMEM16A with a novel monoclonal antibody and EGFR with Cetuximab inhibits the growth and metastasis of esophageal squamous cell carcinoma.

Yutian Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.